A new antiviral drug with both anti-HSV and anti-HIV activity was synthesized by coupling Acyclovir and the acyclic nucleoside phosphonate (R)PMPA. The heterodinucleotide ACVpPMPA encapsulated into autologous erythrocytes was added to human macrophages providing an effective in vitro protection from HSV-1 and HIV-1 replication.
|Number of pages||2|
|Journal||Nucleosides and Nucleotides|
|Publication status||Published - 1999|
ASJC Scopus subject areas